首页 > 最新文献

中华肝胆外科杂志最新文献

英文 中文
A case of hepatic hematoma caused by acute calculous cholecystitis with occult gallbladder perforation 急性结石性胆囊炎并发隐匿性胆囊穿孔致肝血肿1例
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.017
Ningjie Zhou, J. Yao, Jian Wang
急性结石性胆囊炎致肝血肿临床罕见,是胆囊结石穿孔造成肝脏出血的一个特殊表现。对于单纯性肝血肿患者临床可密切观察,择机采取合适的治疗方式。而胆囊结石并急性炎症穿孔出现肝脏血肿的患者,应尽早手术、清除血肿、切除坏死失活肝组织,对破裂的胆管和(或)血管进行结扎或修补,充分引流,以减少血肿感染及严重并发症的发生。本文报道一例急性结石性胆囊炎并隐匿性胆囊穿孔致肝血肿患者的诊疗情况,并查阅相关文献进行讨论。
Acute calculous cholecystitis causing liver hematoma is a rare clinical manifestation, which is a special manifestation of liver bleeding caused by perforation of gallbladder stones. For patients with simple liver hematoma, close observation can be conducted clinically and appropriate treatment methods can be chosen according to the timing. Patients with gallstones and acute inflammatory perforation who develop liver hematoma should undergo surgery as soon as possible, remove the hematoma, remove necrotic and inactive liver tissue, ligate or repair the ruptured bile ducts and/or blood vessels, and provide sufficient drainage to reduce hematoma infection and serious complications. This article reports on the diagnosis and treatment of a patient with acute calculous cholecystitis and occult gallbladder perforation leading to liver hematoma, and reviews relevant literature for discussion.
{"title":"A case of hepatic hematoma caused by acute calculous cholecystitis with occult gallbladder perforation","authors":"Ningjie Zhou, J. Yao, Jian Wang","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.017","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.017","url":null,"abstract":"急性结石性胆囊炎致肝血肿临床罕见,是胆囊结石穿孔造成肝脏出血的一个特殊表现。对于单纯性肝血肿患者临床可密切观察,择机采取合适的治疗方式。而胆囊结石并急性炎症穿孔出现肝脏血肿的患者,应尽早手术、清除血肿、切除坏死失活肝组织,对破裂的胆管和(或)血管进行结扎或修补,充分引流,以减少血肿感染及严重并发症的发生。本文报道一例急性结石性胆囊炎并隐匿性胆囊穿孔致肝血肿患者的诊疗情况,并查阅相关文献进行讨论。","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"865-866"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49661898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Hong's pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy on 184 patients 洪胰肠吻合术在腹腔镜胰十二指肠切除术中的应用(附184例报告)
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.011
Qingmin Chen, Yingchao Wang, Songyang Liu, Wei Zhang, Kai Liu, B. Ji
Objective To evaluate the efficacy and safety of Hong's pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. Methods A retrospective analysis was carried out on 184 patients who underwent laparoscopic pancreaticoduodenectomy using Hong's pancreaticojejunostomy (the Hong’s pancreaticojejunostomy group) compared with 100 patients who underwent laparoscopic pancreaticoduodenectomy using traditional pancreaticojejunostomy (the traditional pancreaticojejunostomy group) at Department of Second Hepatobiliary and Pancreatic Surgery, the First Bethune Hospital of Jilin University, from April 2016 to December 2018. The differences between the two anastomotic methods in operation time, pancreaticojejunostomy time, intraoperative blood loss, postoperative hospital stay, postoperative complications, and incidences of pancreatic fistula were compared. Results The operation time, pancreaticojejunostomy time and intraoperative blood loss of the Hong's pancreaticojejunostomy group were significantly less than the traditional pancreaticojejunostomy group [(278.2±49.3) min vs. (337.3±67.4) min, (33.7±6.6) min vs. (46.8±8.5) min, (123.1±44.7) ml vs. (203.8±138.6) ml], respectively, (all P 0.05). Conclusions Hong's pancreaticojejunostomy was safe, rapid and effective compared with traditional pancreaticojejunostomy. It did not increase the incidence of pancreatic fistula. Key words: Pancreaticoduodenectomy; Laparoscopes; Pancreaticojejunostomy
目的评价洪胰肠吻合术在腹腔镜胰十二指肠切除术中的疗效和安全性。方法对184例采用洪氏胰肠吻合术行腹腔镜胰十二指肠切除术的患者(洪氏胰管吻合术组)与100例在第二肝胆科采用传统胰肠吻合术进行腹腔镜胰十二指肠摘除术的患者进行回顾性分析吉林大学白求恩第一医院胰腺外科,2016年4月至2018年12月。比较两种吻合方法在手术时间、胰肠吻合术时间、术中出血量、术后住院时间、术后并发症和胰瘘发生率方面的差异。结果洪氏胰肠造口术组的手术时间、胰肠造口时间和术中出血量分别显著少于传统胰肠造口组[(278.2±49.3)minvs.(337.3±67.4)min[(33.7±6.6)minvs(46.8±8.5)min[、(123.1±44.7)mlvs.(203.8±138.6)ml],结论与传统胰肠吻合术相比,洪胰肠吻合术安全、快速、有效。它并没有增加胰瘘的发生率。关键词:胰十二指肠切除术;腹腔镜;胰肠造口术
{"title":"Application of Hong's pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy on 184 patients","authors":"Qingmin Chen, Yingchao Wang, Songyang Liu, Wei Zhang, Kai Liu, B. Ji","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.011","url":null,"abstract":"Objective \u0000To evaluate the efficacy and safety of Hong's pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. \u0000 \u0000 \u0000Methods \u0000A retrospective analysis was carried out on 184 patients who underwent laparoscopic pancreaticoduodenectomy using Hong's pancreaticojejunostomy (the Hong’s pancreaticojejunostomy group) compared with 100 patients who underwent laparoscopic pancreaticoduodenectomy using traditional pancreaticojejunostomy (the traditional pancreaticojejunostomy group) at Department of Second Hepatobiliary and Pancreatic Surgery, the First Bethune Hospital of Jilin University, from April 2016 to December 2018. The differences between the two anastomotic methods in operation time, pancreaticojejunostomy time, intraoperative blood loss, postoperative hospital stay, postoperative complications, and incidences of pancreatic fistula were compared. \u0000 \u0000 \u0000Results \u0000The operation time, pancreaticojejunostomy time and intraoperative blood loss of the Hong's pancreaticojejunostomy group were significantly less than the traditional pancreaticojejunostomy group [(278.2±49.3) min vs. (337.3±67.4) min, (33.7±6.6) min vs. (46.8±8.5) min, (123.1±44.7) ml vs. (203.8±138.6) ml], respectively, (all P 0.05). \u0000 \u0000 \u0000Conclusions \u0000Hong's pancreaticojejunostomy was safe, rapid and effective compared with traditional pancreaticojejunostomy. It did not increase the incidence of pancreatic fistula. \u0000 \u0000 \u0000Key words: \u0000Pancreaticoduodenectomy; Laparoscopes; Pancreaticojejunostomy","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"842-845"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49440252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Emergent Meso-Rex shunt to treat intraoperative unrepairable portal vein rupture: a case report 紧急Meso-Rex分流术治疗术中不可修复的门静脉破裂1例
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.016
Xiangfei Meng, W. Duan, Yingwei Pan, X. Shi, Zhiqiang Wang, Ya-dong Sun, Shi-xin Lu
报道首例术中紧急Meso-Rex分流术治疗不可修复的门静脉破裂。患者男性,68岁,因"脂肪肉瘤切除术后复发"入院。诊断为复发性脂肪肉瘤拟行手术切除。肿瘤位于门静脉主干后方,被下腔静脉、腹腔干、肠系膜上动脉等重要血管包绕。术中分离肿瘤时,门静脉后壁破裂,破口直达脾静脉汇合至肠系膜上静脉处,无法修复,被迫封闭门静脉主干。为纠正急性肝前型门静脉高压,以人工血管行Meso-Rex分流术,成功恢复门静脉血流。术后患者恢复顺利,至今随访1年余生存良好。
Report the first intraoperative emergency Meso Rex shunt for the treatment of irreparable portal vein rupture. The patient, a 68 year old male, was admitted due to "recurrence after liposarcoma resection". Diagnosed as recurrent liposarcoma, surgical resection is planned. The tumor is located behind the main portal vein and is surrounded by important blood vessels such as the inferior vena cava, abdominal trunk, and superior mesenteric artery. During the surgical separation of the tumor, the posterior wall of the portal vein ruptured, leading directly to the confluence of the splenic vein and the superior mesenteric vein, which could not be repaired and forced to seal the main portal vein. To correct acute prehepatic portal hypertension, a Meso Rex shunt was performed using an artificial blood vessel to successfully restore portal vein blood flow. The postoperative patient recovered smoothly and has been followed up for more than 1 year with good survival.
{"title":"Emergent Meso-Rex shunt to treat intraoperative unrepairable portal vein rupture: a case report","authors":"Xiangfei Meng, W. Duan, Yingwei Pan, X. Shi, Zhiqiang Wang, Ya-dong Sun, Shi-xin Lu","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.016","url":null,"abstract":"报道首例术中紧急Meso-Rex分流术治疗不可修复的门静脉破裂。患者男性,68岁,因\"脂肪肉瘤切除术后复发\"入院。诊断为复发性脂肪肉瘤拟行手术切除。肿瘤位于门静脉主干后方,被下腔静脉、腹腔干、肠系膜上动脉等重要血管包绕。术中分离肿瘤时,门静脉后壁破裂,破口直达脾静脉汇合至肠系膜上静脉处,无法修复,被迫封闭门静脉主干。为纠正急性肝前型门静脉高压,以人工血管行Meso-Rex分流术,成功恢复门静脉血流。术后患者恢复顺利,至今随访1年余生存良好。","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"863-864"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47756031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New progress in donor protection for liver transplantation 肝移植供体保护的新进展
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.019
Ning Zhang
Liver transplantation is the unique effective life-saving procedure for patients suffering from end-stage liver diseases. The gap between the number of donor graft and patients in waiting lists dramatically increased and the shortage of donors becomes a severe challenge in liver transplantation. At present, the organ donation after death is the only source of organ transplantation in China. Ischemia-reperfusion injury significantly affects the quality of donor liver and the prognosis of recipient transplantation. Therefore, reasonable and effective organ protection techniques and strategies have received much concern in recent years. Here we reviewed the new progress in donor liver preservation and retrieval, surgical ischemia conditioning, drug intervention as well as gene therapy. Key words: Liver transplantation; Reperfusion injury; Donor protection
肝移植是治疗终末期肝病的唯一有效的挽救生命的方法。供体移植物的数量和等待名单上的患者之间的差距急剧增加,供体短缺成为肝移植的一个严重挑战。目前,死亡后的器官捐献是中国器官移植的唯一来源。缺血再灌注损伤严重影响供肝质量和受体移植的预后。因此,合理有效的器官保护技术和策略近年来备受关注。本文综述了供肝保存和修复、手术缺血预处理、药物干预以及基因治疗等方面的最新进展。关键词:肝移植;再灌注损伤;捐助者保护
{"title":"New progress in donor protection for liver transplantation","authors":"Ning Zhang","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.019","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.019","url":null,"abstract":"Liver transplantation is the unique effective life-saving procedure for patients suffering from end-stage liver diseases. The gap between the number of donor graft and patients in waiting lists dramatically increased and the shortage of donors becomes a severe challenge in liver transplantation. At present, the organ donation after death is the only source of organ transplantation in China. Ischemia-reperfusion injury significantly affects the quality of donor liver and the prognosis of recipient transplantation. Therefore, reasonable and effective organ protection techniques and strategies have received much concern in recent years. Here we reviewed the new progress in donor liver preservation and retrieval, surgical ischemia conditioning, drug intervention as well as gene therapy. \u0000 \u0000 \u0000Key words: \u0000Liver transplantation; Reperfusion injury; Donor protection","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"868-871"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42079214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of different staging methods on radical resection rate and prognosis of patients with hilar cholangiocarcinoma 不同分期方法对肝门部胆管癌根治率及预后的影响
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.008
Q. Xin, Xiaoyuan Yu, Xing-kai Liu, Ping Zhang
Objective To compare the Bismuth-Corlette typing, modified T-staging and Mayo staging system in predicting the radical resection rates and prognosis of patients with hilar cholangiocarcinoma (HCC). Methods The clinical data of 138 patients with hilar cholangiocarcinoma treated in the First Bethune Hospital of Jilin University were retrospectively analyzed. Three different staging methods were used. Results With increase in the classification level of the Bismuth-Corlette classification, the radical resection rate did not significantly decrease (P>0.05). The radical resection rates of stage T1, T2 and T3 in the modified T-staging system were 60.0% (27/45), 36.0% (10/28) and 14.0% (9/65) respectively (all P 0.05). However, there were significant differences among the survival rates in the various tumor staging levels using the Mayo Staging System. Conclusions The modified T-staging system and the Mayo staging system were more accurate than the Bismuth-Corlette typing system in predicting radical resection rates in patients with hilar cholangiocarcinoma. The Mayo staging system was superior to the Bismuth-Corlette typing system and the modified T-staging system in predicting prognosis of patients with hilar cholangiocarcinoma. Key words: Bile duct neoplasms; Prognosis; Bismuth-Corlette typing system; Modified T-staging system; Mayo staging system; Hilar cholangiocarcinoma; Radical resection
目的比较Bismuth-Corlette分型、改良t分期和Mayo分期对肝门部胆管癌(HCC)根治率和预后的预测价值。方法回顾性分析吉林大学白求恩第一医院收治的138例肝门部胆管癌患者的临床资料。采用了三种不同的分期方法。结果随着Bismuth-Corlette分级水平的提高,根治率无显著降低(P < 0.05)。改良t分期系统T1、T2、T3期根治率分别为60.0%(27/45)、36.0%(10/28)、14.0%(9/65),差异均有统计学意义(P均0.05)。然而,使用Mayo分期系统的不同肿瘤分期水平的生存率存在显著差异。结论改良t分期系统和Mayo分期系统比Bismuth-Corlette分型系统预测肝门部胆管癌根治率更准确。Mayo分期系统在预测肝门部胆管癌患者预后方面优于Bismuth-Corlette分型系统和改良t分期系统。关键词:胆管肿瘤;预后;铋-柯莱特打字系统;改进的t分期系统;Mayo分期系统;门的胆管癌;彻底的切除
{"title":"Evaluation of different staging methods on radical resection rate and prognosis of patients with hilar cholangiocarcinoma","authors":"Q. Xin, Xiaoyuan Yu, Xing-kai Liu, Ping Zhang","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.008","url":null,"abstract":"Objective \u0000To compare the Bismuth-Corlette typing, modified T-staging and Mayo staging system in predicting the radical resection rates and prognosis of patients with hilar cholangiocarcinoma (HCC). \u0000 \u0000 \u0000Methods \u0000The clinical data of 138 patients with hilar cholangiocarcinoma treated in the First Bethune Hospital of Jilin University were retrospectively analyzed. Three different staging methods were used. \u0000 \u0000 \u0000Results \u0000With increase in the classification level of the Bismuth-Corlette classification, the radical resection rate did not significantly decrease (P>0.05). The radical resection rates of stage T1, T2 and T3 in the modified T-staging system were 60.0% (27/45), 36.0% (10/28) and 14.0% (9/65) respectively (all P 0.05). However, there were significant differences among the survival rates in the various tumor staging levels using the Mayo Staging System. \u0000 \u0000 \u0000Conclusions \u0000The modified T-staging system and the Mayo staging system were more accurate than the Bismuth-Corlette typing system in predicting radical resection rates in patients with hilar cholangiocarcinoma. The Mayo staging system was superior to the Bismuth-Corlette typing system and the modified T-staging system in predicting prognosis of patients with hilar cholangiocarcinoma. \u0000 \u0000 \u0000Key words: \u0000Bile duct neoplasms; Prognosis; Bismuth-Corlette typing system; Modified T-staging system; Mayo staging system; Hilar cholangiocarcinoma; Radical resection","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"828-833"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46978249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of indocyanine green fluorescence imaging in open hepatectomy 吲哚青绿荧光成像在开放性肝切除术中的应用
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.003
Pan He, S. Su, Cheng Fang, K. He, Chongwei Chi, X. Xia, Jie Tian, Bo Li
Objective To investigate the clinical application of indocyanine green fluorescence imaging in open hepatectomy. Methods A total of forty-five patients who underwent liver resection in Department of Hepatobiliary Surgery, Affiliated Hospital of Southwest Medical University from July 2017 to December 2018 were included in this prospective study. There were 26 males and 19 females, aged between 29 to 74 (51±10) years. Indocyanine green was injected intravenously 72~96 hours prior to surgery in all these patients. An intraoperative fluorescence imaging system was used to locate and remove the tumor, the liver parenchymal transection planes and surgical margins were detected by fluorescence again after tumor resection. The fluorescence profiles of the tumor specimens in relation to the tumor differentiation were analyzed. Results Indocyanine green fluorescence imaging was performed in 45 patients. A total of 66 lesions were detected by preoperative CT (or MRI), abdominal ultrasound and intraoperative fluorescence imaging. After excision of the primary liver cancer, the surgical margins of the remnant liver stumps and fluorescence in the excised liver specimens were studied. Thirteen small lesions were found in 10 patients, most of which were located at the surgical margin, and the smallest tumors detected were less than 5 mm in diameter. Five venous cancer emboli were found in 5 patients, 3 of which were not detected by preoperative imaging examinations. The fluorescence profile images of the excised hepatocellular carcinoma specimens showed homogeneous fluorescence in most highly differentiated hepatocellular carcinoma, and partial fluorescence or ring fluorescence in moderately differentiated hepatocellular carcinoma. Conclusion Indocyanine green fluorescence imaging technology can identify liver surface lesions, as well as detect small residual lesions at the cutting edge and venous thrombus, which improves the efficiency of hepatocellular carcinoma resection. Key words: Hepatectomy; Margins of excision; Indocyanine green; Fluorescence imaging
目的探讨吲哚青绿荧光显像在肝切除术中的临床应用。方法将2017年7月至2018年12月在西南医科大学附属医院肝胆外科接受肝切除术的45例患者纳入本前瞻性研究。共有26名男性和19名女性,年龄在29至74(51±10)岁之间。所有患者术前72~96小时静脉注射吲哚菁绿。术中使用荧光成像系统定位和切除肿瘤,肿瘤切除后再次通过荧光检测肝实质横断平面和手术边缘。分析了肿瘤标本的荧光图谱与肿瘤分化的关系。结果对45例患者进行吲哚青绿荧光成像。术前CT(或MRI)、腹部超声和术中荧光成像共检测到66个病变。原发性肝癌癌症切除后,对残肝残端的手术切缘和切除肝标本中的荧光进行了研究。在10名患者中发现了13个小病变,其中大多数位于手术边缘,检测到的最小肿瘤直径小于5毫米。5例患者发现5个癌症静脉栓塞,其中3例术前影像学检查未发现。切除的肝细胞癌标本的荧光图谱图像在大多数高分化肝细胞癌中显示均匀荧光,在中分化肝细胞瘤中显示部分荧光或环状荧光。结论吲哚菁绿色荧光成像技术能够识别肝表面病变,并能检测出切缘微小残留病变和静脉血栓,提高了肝细胞癌切除的效率。关键词:肝切除术;切除边缘;吲哚菁绿;荧光成像
{"title":"Application of indocyanine green fluorescence imaging in open hepatectomy","authors":"Pan He, S. Su, Cheng Fang, K. He, Chongwei Chi, X. Xia, Jie Tian, Bo Li","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.003","url":null,"abstract":"Objective \u0000To investigate the clinical application of indocyanine green fluorescence imaging in open hepatectomy. \u0000 \u0000 \u0000Methods \u0000A total of forty-five patients who underwent liver resection in Department of Hepatobiliary Surgery, Affiliated Hospital of Southwest Medical University from July 2017 to December 2018 were included in this prospective study. There were 26 males and 19 females, aged between 29 to 74 (51±10) years. Indocyanine green was injected intravenously 72~96 hours prior to surgery in all these patients. An intraoperative fluorescence imaging system was used to locate and remove the tumor, the liver parenchymal transection planes and surgical margins were detected by fluorescence again after tumor resection. The fluorescence profiles of the tumor specimens in relation to the tumor differentiation were analyzed. \u0000 \u0000 \u0000Results \u0000Indocyanine green fluorescence imaging was performed in 45 patients. A total of 66 lesions were detected by preoperative CT (or MRI), abdominal ultrasound and intraoperative fluorescence imaging. After excision of the primary liver cancer, the surgical margins of the remnant liver stumps and fluorescence in the excised liver specimens were studied. Thirteen small lesions were found in 10 patients, most of which were located at the surgical margin, and the smallest tumors detected were less than 5 mm in diameter. Five venous cancer emboli were found in 5 patients, 3 of which were not detected by preoperative imaging examinations. The fluorescence profile images of the excised hepatocellular carcinoma specimens showed homogeneous fluorescence in most highly differentiated hepatocellular carcinoma, and partial fluorescence or ring fluorescence in moderately differentiated hepatocellular carcinoma. \u0000 \u0000 \u0000Conclusion \u0000Indocyanine green fluorescence imaging technology can identify liver surface lesions, as well as detect small residual lesions at the cutting edge and venous thrombus, which improves the efficiency of hepatocellular carcinoma resection. \u0000 \u0000 \u0000Key words: \u0000Hepatectomy; Margins of excision; Indocyanine green; Fluorescence imaging","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"809-811"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42369824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress of liver transplantation in treating hepatic epithelioid hemangioendothelioma 肝移植治疗肝上皮样血管内皮瘤的研究进展
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.021
H. Wen, Lin-wei Wu
Epithelioid Hemangioendotheliomais a rare, low-grade malignant vascular tumour. It’scalled hepatic epithelioid hemangioendothelioma(HEHE), when it occurs in liver. It can be metastatic and postoperative recurrence. There are few cases have been reported in the literature at home and abroad because of its rarity. The treatment of HEHE is also controversial. With the continuous improvement of surgical techniques of liver transplantation, it is increasingly applied to treat liver failure patients caused by HEHE. Our paper reviews the literature on disease characteristics of HEHE, and liver transplantation for HEHE indications, immunotherapy and prognosis, to illustrate the status and progress of liver transplantation for HEHE. Key words: Liver transplantation; Neoplasm metastasis; Recurrence; Epithelioid hemangioendothelioma
上皮样血管内皮瘤是一种罕见的低级别恶性血管肿瘤。当它发生在肝脏时被称为肝上皮样血管内皮瘤(HEHE)。它可以转移和术后复发。由于其罕见性,国内外文献报道的病例很少。HEHE的治疗也存在争议。随着肝移植手术技术的不断提高,越来越多地应用于治疗HEHE引起的肝功能衰竭患者。本文就HEHE的疾病特点、肝移植的适应症、免疫治疗及预后等方面的文献进行综述,阐述HEHE肝移植的现状及进展。关键词:肝移植;肿瘤转移;复发;上皮样血管内皮瘤
{"title":"Progress of liver transplantation in treating hepatic epithelioid hemangioendothelioma","authors":"H. Wen, Lin-wei Wu","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.021","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.021","url":null,"abstract":"Epithelioid Hemangioendotheliomais a rare, low-grade malignant vascular tumour. It’scalled hepatic epithelioid hemangioendothelioma(HEHE), when it occurs in liver. It can be metastatic and postoperative recurrence. There are few cases have been reported in the literature at home and abroad because of its rarity. The treatment of HEHE is also controversial. With the continuous improvement of surgical techniques of liver transplantation, it is increasingly applied to treat liver failure patients caused by HEHE. Our paper reviews the literature on disease characteristics of HEHE, and liver transplantation for HEHE indications, immunotherapy and prognosis, to illustrate the status and progress of liver transplantation for HEHE. \u0000 \u0000 \u0000Key words: \u0000Liver transplantation; Neoplasm metastasis; Recurrence; Epithelioid hemangioendothelioma","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"875-878"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42719314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of clinical application of ALPPS for hepatocellular carcinoma with mild-to-moderate liver cirrhosis ALPPS治疗肝癌合并轻中度肝硬化的临床应用分析
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.002
Li Chunhong, Deng Mingwu, Qiu Siyuan, Zhu Hongtao, Xu Bangren, Hong Xiaoming, Ji-hua Ren, Wu Guoji, Chen Zhi-ren, Zhang Dantu, Lu Chongmao
Objective To study the application of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma with mild-to-moderate liver cirrhosis. Methods There are 14 patients with hepatocellular carcinoma underwent ALPPS at the Department of Hepatobiliary and Pancreatic Surgery, Hong Kong University-Shenzhen Hospital from April 2014 to December 2017. The clinical data was retrospectively studied. The studying objects consisted of 9 males and 5 females, aged from 26 to 71 years old with the average age of 51, all cases were of Child-Pugh grade A. The degree of liver cirrhosis, operation and postoperative complications were analyzed. Results All 14 patients completed the ALPPS, 1 patient died post stage 2 operation with liver failure. Comparing the groups with no liver cirrhosis (n=4) with the groups of mild liver cirrhosis (n=5) and moderate liver cirrhosis (n=5), the future liver remnant liver volume growth rates were 58%, 46% and 45.6%, respectively. The average operation intervals were 9.0, 11.2 and 12.8 days, respectively. Postoperative complications occurred in 4 patients: 2 patients with liver failure, 1 patient with intestinal obstruction, and 1 patient with hepatic ascites. Conclusion ALPPS for Child-Pugh grade A, hepatocellular carcinoma with mild-to-moderate liver cirrhosis treatment is safe and feasible. Key words: Liver cirrhosis; Carcinoma, hepatocelluar; Hepatectomy; Associating liver partition and portal vein ligation for staged hepatectomy
目的探讨联合肝分区门静脉结扎在肝细胞癌合并轻中度肝硬化的分期肝切除术中的应用。方法选取2014年4月至2017年12月在香港大学-深圳医院肝胆胰外科行肝细胞癌ALPPS治疗的14例患者。回顾性分析临床资料。研究对象男9例,女5例,年龄26 ~ 71岁,平均年龄51岁,均为Child-Pugh a级,分析肝硬化程度、手术情况及术后并发症。结果14例患者均完成了ALPPS, 1例患者在二期手术后因肝功能衰竭死亡。无肝硬化组(n=4)与轻度肝硬化组(n=5)、中度肝硬化组(n=5)比较,未来肝残肝体积增长率分别为58%、46%和45.6%。平均手术间隔分别为9.0、11.2和12.8 d。术后出现并发症4例,其中肝功能衰竭2例,肠梗阻1例,肝性腹水1例。结论ALPPS治疗Child-Pugh A级肝癌合并轻中度肝硬化是安全可行的。关键词:肝硬化;癌,hepatocelluar;肝切除术;联合肝分区和门静脉结扎在分期肝切除术中的应用
{"title":"Analysis of clinical application of ALPPS for hepatocellular carcinoma with mild-to-moderate liver cirrhosis","authors":"Li Chunhong, Deng Mingwu, Qiu Siyuan, Zhu Hongtao, Xu Bangren, Hong Xiaoming, Ji-hua Ren, Wu Guoji, Chen Zhi-ren, Zhang Dantu, Lu Chongmao","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.002","url":null,"abstract":"Objective \u0000To study the application of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma with mild-to-moderate liver cirrhosis. \u0000 \u0000 \u0000Methods \u0000There are 14 patients with hepatocellular carcinoma underwent ALPPS at the Department of Hepatobiliary and Pancreatic Surgery, Hong Kong University-Shenzhen Hospital from April 2014 to December 2017. The clinical data was retrospectively studied. The studying objects consisted of 9 males and 5 females, aged from 26 to 71 years old with the average age of 51, all cases were of Child-Pugh grade A. The degree of liver cirrhosis, operation and postoperative complications were analyzed. \u0000 \u0000 \u0000Results \u0000All 14 patients completed the ALPPS, 1 patient died post stage 2 operation with liver failure. Comparing the groups with no liver cirrhosis (n=4) with the groups of mild liver cirrhosis (n=5) and moderate liver cirrhosis (n=5), the future liver remnant liver volume growth rates were 58%, 46% and 45.6%, respectively. The average operation intervals were 9.0, 11.2 and 12.8 days, respectively. Postoperative complications occurred in 4 patients: 2 patients with liver failure, 1 patient with intestinal obstruction, and 1 patient with hepatic ascites. \u0000 \u0000 \u0000Conclusion \u0000ALPPS for Child-Pugh grade A, hepatocellular carcinoma with mild-to-moderate liver cirrhosis treatment is safe and feasible. \u0000 \u0000 \u0000Key words: \u0000Liver cirrhosis; Carcinoma, hepatocelluar; Hepatectomy; Associating liver partition and portal vein ligation for staged hepatectomy","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"806-808"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47350705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The progress and advances of biliary tract carcinoma chemotherapy 胆道癌化疗的进展与进展
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.022
Xiaofan Li
Compared with other tumors of digestive system such as colorectal cancer, the overall survival for advanced biliary tract carcinoma has not been prolonged greatly although some progress has been made on the optimization of the treatment. One of the reasons is that there is no effective chemotherapy for biliary tract cancer yet. In this review, we summarized the recent research findings on chemotherapy for BTC , thereby providing guidance on clinical practice. Key words: Biliary tract neoplasms; Antineoplastic combined chemotherapy protocols; Review
与结肠直肠癌等其他消化系统肿瘤相比,晚期胆道癌的总生存期并没有明显延长,但在优化治疗方面取得了一些进展。其中一个原因是目前还没有针对胆道癌的有效化疗方法。本文就近年来BTC的化疗研究成果进行综述,以期对临床治疗提供指导。关键词:胆道肿瘤;抗肿瘤联合化疗方案;审查
{"title":"The progress and advances of biliary tract carcinoma chemotherapy","authors":"Xiaofan Li","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.022","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.022","url":null,"abstract":"Compared with other tumors of digestive system such as colorectal cancer, the overall survival for advanced biliary tract carcinoma has not been prolonged greatly although some progress has been made on the optimization of the treatment. One of the reasons is that there is no effective chemotherapy for biliary tract cancer yet. In this review, we summarized the recent research findings on chemotherapy for BTC , thereby providing guidance on clinical practice. \u0000 \u0000 \u0000Key words: \u0000Biliary tract neoplasms; Antineoplastic combined chemotherapy protocols; Review","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"878-880"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46435623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of reduced-volume hepatectomy for advanced hepatic alveolar echinococcosis 小容量肝切除术治疗晚期肝泡包虫病的安全性和有效性
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1007-8118.2019.11.004
Shunyun Zhao, Yamin Guo, A. Jide, Zhe Peng, Xiang-Tian Wang, Wei Gao, R. Jin, Zhanxue Zhao
Objective To evaluate the efficacy and safety of reduced volume hepatectomy in treatment of advanced hepatic alveolar echinococcosis. Methods The clinical data of 90 patients with advanced hepatic alveolar echinococcosis treated at the Qinghai Provincial People's Hospital from January 2017 to January 2019 were retrospectively analyzed. There were 41 males and 49 females, with an average age of 32 (range 11 to 58) years. The locations of the lesions, operations, complications and follow-up were analyzed. Results 90 patients were treated with reduced volume focal hepatectomy, 38 with radical resection and 52 with quasi radical resection. The operation time was (361±22) min. The hospital stay was (22±2) day, and the blood loss was (781±37) ml. Red blood cells were transfused in 19 patients and plasma in 39 patients. Pringle’s maneuver was used in 12 patients, regional hepatic blood flow occlusion in 42 patients, and Glisson sheath occlusion in 26 patients. The total bilirubin, alanine aminotransferase and aspartate aminotransferase returned to normal in 3 to 14 days after operation. There were 12 patients who developed bile leakage, 41 pleural effusion and 26 effusion in the operation sites. A total of ninety patients were followed up for 2 to 24 months. There was no recurrence of echinococcosis after radical resection and no enlargement of residual lesions after quasi-radical resection. Conclusion Reduced-volume hepatectomy reduced the risk and difficulty of operation. The follow-up results were good. This approach provides a feasible scheme for treatment of advanced hepatic alveolar echinococcosis. Key words: Echinococcosis, hepatic; Treatment outcome; Reduced-volume focal hepatectomy; Safety
目的评价减容肝切除术治疗晚期肝泡状棘球蚴病的疗效和安全性。方法回顾性分析2017年1月至2019年1月青海省人民医院收治的90例晚期肝泡状棘球蚴病患者的临床资料。共有41名男性和49名女性,平均年龄为32岁(11至58岁)。分析病变部位、手术、并发症及随访情况。结果90例患者采用缩小体积局灶性肝切除术,38例采用根治性切除术,52例采用准根治性切除。手术时间为(361±22)min,住院时间为(22±2)天,出血量为(781±37)ml。19例患者输注红细胞,39例患者输血浆。Pringle手法用于12例患者,区域性肝血流阻断用于42例患者,Glisson鞘管阻断用于26例患者。术后3~14天,总胆红素、丙氨酸氨基转移酶和天冬氨酸氨基转移酶均恢复正常。12例患者出现胆汁渗漏,41例胸腔积液,26例手术部位积液。共有90名患者接受了2至24个月的随访。棘球蚴病根治术后无复发,准根治术后残余病灶无扩大。结论缩小体积肝切除术降低了手术风险和难度。随访结果良好。该方法为晚期肝泡状棘球蚴病的治疗提供了一种可行的方案。关键词:棘球蚴病,肝;治疗结果;缩小体积局灶性肝切除术;安全
{"title":"Safety and efficacy of reduced-volume hepatectomy for advanced hepatic alveolar echinococcosis","authors":"Shunyun Zhao, Yamin Guo, A. Jide, Zhe Peng, Xiang-Tian Wang, Wei Gao, R. Jin, Zhanxue Zhao","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.11.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.11.004","url":null,"abstract":"Objective \u0000To evaluate the efficacy and safety of reduced volume hepatectomy in treatment of advanced hepatic alveolar echinococcosis. \u0000 \u0000 \u0000Methods \u0000The clinical data of 90 patients with advanced hepatic alveolar echinococcosis treated at the Qinghai Provincial People's Hospital from January 2017 to January 2019 were retrospectively analyzed. There were 41 males and 49 females, with an average age of 32 (range 11 to 58) years. The locations of the lesions, operations, complications and follow-up were analyzed. \u0000 \u0000 \u0000Results \u000090 patients were treated with reduced volume focal hepatectomy, 38 with radical resection and 52 with quasi radical resection. The operation time was (361±22) min. The hospital stay was (22±2) day, and the blood loss was (781±37) ml. Red blood cells were transfused in 19 patients and plasma in 39 patients. Pringle’s maneuver was used in 12 patients, regional hepatic blood flow occlusion in 42 patients, and Glisson sheath occlusion in 26 patients. The total bilirubin, alanine aminotransferase and aspartate aminotransferase returned to normal in 3 to 14 days after operation. There were 12 patients who developed bile leakage, 41 pleural effusion and 26 effusion in the operation sites. A total of ninety patients were followed up for 2 to 24 months. There was no recurrence of echinococcosis after radical resection and no enlargement of residual lesions after quasi-radical resection. \u0000 \u0000 \u0000Conclusion \u0000Reduced-volume hepatectomy reduced the risk and difficulty of operation. The follow-up results were good. This approach provides a feasible scheme for treatment of advanced hepatic alveolar echinococcosis. \u0000 \u0000 \u0000Key words: \u0000Echinococcosis, hepatic; Treatment outcome; Reduced-volume focal hepatectomy; Safety","PeriodicalId":10021,"journal":{"name":"Chinese Journal of Hepatobiliary Surgery","volume":"25 1","pages":"812-814"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47355694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
中华肝胆外科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1